438 related articles for article (PubMed ID: 26840087)
1. Blastic plasmacytoid dendritic cell neoplasm frequently shows occult central nervous system involvement at diagnosis and benefits from intrathecal therapy.
Martín-Martín L; Almeida J; Pomares H; González-Barca E; Bravo P; Giménez T; Heras C; Queizán JA; Pérez-Ceballos E; Martínez V; Alonso N; Calvo C; Álvarez R; Caballero MD; Orfao A
Oncotarget; 2016 Mar; 7(9):10174-81. PubMed ID: 26840087
[TBL] [Abstract][Full Text] [Related]
2. [Blastic plasmacytoid dendritic cell neoplasm with complete clinical remission with chemotherapy and central nervous system relapse: Report of one case].
Contreras L; Mercado L; Delgado C; Cabezas C; Starke L; Romero M; Ibieta F; Henríquez M; Chandia M
Rev Med Chil; 2017 Jan; 145(1):115-120. PubMed ID: 28393977
[TBL] [Abstract][Full Text] [Related]
3. Blastic plasmacytoid dendritic cell neoplasm: update on therapy especially novel agents.
Wang S; Wang X; Liu M; Bai O
Ann Hematol; 2018 Apr; 97(4):563-572. PubMed ID: 29455234
[TBL] [Abstract][Full Text] [Related]
4. Blastic plasmacytoid dendritic cell neoplasm: update on molecular biology, diagnosis, and therapy.
Riaz W; Zhang L; Horna P; Sokol L
Cancer Control; 2014 Oct; 21(4):279-89. PubMed ID: 25310209
[TBL] [Abstract][Full Text] [Related]
5. Blastic plasmacytoid dendritic cell neoplasm: clinical features in 90 patients.
Julia F; Petrella T; Beylot-Barry M; Bagot M; Lipsker D; Machet L; Joly P; Dereure O; Wetterwald M; d'Incan M; Grange F; Cornillon J; Tertian G; Maubec E; Saiag P; Barete S; Templier I; Aubin F; Dalle S
Br J Dermatol; 2013 Sep; 169(3):579-86. PubMed ID: 23646868
[TBL] [Abstract][Full Text] [Related]
6. Blastic plasmacytoid dendritic cell neoplasm: report of a case presenting with lung and central nervous system involvement and review of the literature.
Feng Z; Zhou J; Bentley G
J La State Med Soc; 2014; 166(1):2-9. PubMed ID: 25075501
[TBL] [Abstract][Full Text] [Related]
7. Blastic Plasmacytoid Dendritic Cell Neoplasm: A Comprehensive Review of the Disease, Central Nervous System Presentations, and Treatment Strategies.
Mehra S; Taylor J
Cells; 2024 Jan; 13(3):. PubMed ID: 38334635
[TBL] [Abstract][Full Text] [Related]
8. Myeloid Cell Nuclear Differentiation Antigen (MNDA) Expression Distinguishes Extramedullary Presentations of Myeloid Leukemia From Blastic Plasmacytoid Dendritic Cell Neoplasm.
Johnson RC; Kim J; Natkunam Y; Sundram U; Freud AG; Gammon B; Cascio MJ
Am J Surg Pathol; 2016 Apr; 40(4):502-9. PubMed ID: 26796502
[TBL] [Abstract][Full Text] [Related]
9. Blastic plasmacytoid dendritic cell neoplasm: diagnostic criteria and therapeutical approaches.
Pagano L; Valentini CG; Grammatico S; Pulsoni A
Br J Haematol; 2016 Jul; 174(2):188-202. PubMed ID: 27264021
[TBL] [Abstract][Full Text] [Related]
10. New perspectives in genetics and targeted therapy for blastic plasmacytoid dendritic cell neoplasm.
Zhang X; Sun J; Yang M; Wang L; Jin J
Crit Rev Oncol Hematol; 2020 May; 149():102928. PubMed ID: 32234682
[TBL] [Abstract][Full Text] [Related]
11. Unique presentation of blastic plasmacytoid dendritic cell neoplasm: a single-center experience and literature review.
Paluri R; Nabell L; Borak S; Peker D
Hematol Oncol; 2015 Dec; 33(4):206-11. PubMed ID: 24850172
[TBL] [Abstract][Full Text] [Related]
12. Classification and clinical behavior of blastic plasmacytoid dendritic cell neoplasms according to their maturation-associated immunophenotypic profile.
Martín-Martín L; López A; Vidriales B; Caballero MD; Rodrigues AS; Ferreira SI; Lima M; Almeida S; Valverde B; Martínez P; Ferrer A; Candeias J; Ruíz-Cabello F; Buadesa JM; Sempere A; Villamor N; Orfao A; Almeida J
Oncotarget; 2015 Aug; 6(22):19204-16. PubMed ID: 26056082
[TBL] [Abstract][Full Text] [Related]
13. Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm: A Systematic Literature Review.
Kim MJ; Nasr A; Kabir B; de Nanassy J; Tang K; Menzies-Toman D; Johnston D; El Demellawy D
J Pediatr Hematol Oncol; 2017 Oct; 39(7):528-537. PubMed ID: 28906324
[TBL] [Abstract][Full Text] [Related]
14. Blastic plasmacytoid dendritic cell neoplasm and cerebral toxoplasmosis: a case report.
Florescu AM; Sørensen ALT; Nielsen HV; Tolnai D; Sjö LD; Larsen KL; Al-Karagholi MA
BMC Neurol; 2022 Jun; 22(1):233. PubMed ID: 35751052
[TBL] [Abstract][Full Text] [Related]
15. Multicenter analysis of outcomes in blastic plasmacytoid dendritic cell neoplasm offers a pretargeted therapy benchmark.
Taylor J; Haddadin M; Upadhyay VA; Grussie E; Mehta-Shah N; Brunner AM; Louissaint A; Lovitch SB; Dogan A; Fathi AT; Stone RM; Tallman MS; Rampal RK; Neuberg DS; Stevenson KE; Horwitz SM; Lane AA
Blood; 2019 Aug; 134(8):678-687. PubMed ID: 31243042
[TBL] [Abstract][Full Text] [Related]
16. Blastic plasmacytoid dendritic cell neoplasm (BPDCN): a rare entity.
Lim MS; Lemmert K; Enjeti A
BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26791132
[TBL] [Abstract][Full Text] [Related]
17. Treatment patterns and outcomes of patients with CNS involvement of blastic plasmacytoid dendritic cell neoplasm (BPDCN).
Davis JA; Rizzieri DA; Lane AA; Taylor J; Faisal MS; Vasu S; Soong D; Li H; Herbst A; Greenwell IB
Leuk Lymphoma; 2022 Nov; 63(11):2757-2759. PubMed ID: 35727174
[No Abstract] [Full Text] [Related]
18. Frontline Hyper-CVAD Plus Venetoclax for Pediatric Blastic Plasmacytoid Dendritic Cell Neoplasm.
He J; Garcia MB; Connors JS; Nuñez CA; Quesada AE; Gibson A; Roth M; Cuglievan B; Pemmaraju N; McCall D
J Pediatr Hematol Oncol; 2023 Nov; 45(8):e1001-e1004. PubMed ID: 37661300
[TBL] [Abstract][Full Text] [Related]
19. Blastic plasmacytoid dendritic cell neoplasm: a single-center experience.
An HJ; Yoon DH; Kim S; Shin SJ; Huh J; Lee KH; Suh C
Ann Hematol; 2013 Mar; 92(3):351-6. PubMed ID: 23135479
[TBL] [Abstract][Full Text] [Related]
20. Blastic plasmacytoid dendritic cell neoplasm: evolving insights in an aggressive hematopoietic malignancy with a predilection of skin involvement.
Gera S; Dekmezian MS; Duvic M; Tschen JA; Vega F; Cho-Vega JH
Am J Dermatopathol; 2014 Mar; 36(3):244-51. PubMed ID: 24247574
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
